Inhaled medications are often used to treat lung diseases such as cystic fibrosis. We are
performing this study to determine whether inhaled medications dissolved in surfactant-based
solutions will distribute more evenly throughout the lungs when compared to standard
saline-based solutions. We think that inhaling medication that is in a surfactant-based
liquid will result in more medication reaching partially blocked parts of the lung. This
study will use a special nuclear medicine test called an aerosol deposition scan to compare
how a drug spreads in the lung using a surfactant-based aerosol compared to a saline-based
aerosol.
Phase:
N/A
Details
Lead Sponsor:
University of Pittsburgh
Collaborators:
Cystic Fibrosis Foundation Cystic Fibrosis Foundation Therapeutics